U.S. Medical Equipment Stock News

Analysts recently downgraded Martin Marietta Materials (MLM) after flagging softer aggregate pricing expectations, slower infrastructure bidding, and uncertainty around upcoming transportation policy changes. This has raised fresh questions about the stock’s risk and return profile for investors. See our latest analysis for Martin Marietta Materials. Despite the downgrade, Martin Marietta Materials’ share price has held relatively firm, with a 30 day share price return of 5.96% and a 1 year...

Revenue guidance and what changed for Red Cat Red Cat Holdings (RCAT) shook up expectations by issuing preliminary 2025 guidance that points to very large fourth quarter revenue growth and more than double full year sales compared with 2024. The company now projects Q4 revenue between US$24.0 million and US$26.5 million, versus the US$1.3 million it reported in the same period a year earlier, alongside full year guidance of US$38.0 million to US$41.0 million compared with US$15.6 million in...

Northern Trust (NTRS) caught investor attention after renewing and expanding its long running mandate with Swedish pension fund AMF Tjanstepension AB, adding investment operations and trade services across AMF's entire global portfolio. See our latest analysis for Northern Trust. The renewed AMF mandate lands while Northern Trust's share price sits at US$145.25, with a 30 day share price return of 4.86% and 90 day share price return of 11.83%, alongside a 1 year total shareholder return of...

Why Xenia Hotels & Resorts is on investors’ radar Xenia Hotels & Resorts (XHR) has been drawing attention after a period where the stock’s past 3 months return sits around 13%, alongside modest revenue growth and a weaker annual net income result. See our latest analysis for Xenia Hotels & Resorts. At a share price of US$14.75, Xenia Hotels & Resorts has seen a 12.94% 90 day share price return, while its 1 year total shareholder return of 4.92% and 5 year figure close to flat suggest momentum...

In recent days, Community Memorial Hospital in Central New York announced it has replaced its legacy health record systems with Oracle Health solutions, including an AI-powered clinical documentation tool and a data-sharing platform to streamline workflows and improve care coordination. This move highlights how Oracle is applying its AI and cloud capabilities beyond hyperscale data centers into practical, day-to-day healthcare operations at smaller regional providers. We’ll now examine how...

Why Tenet Healthcare is on investors’ radar today Tenet Healthcare (THC) has been drawing attention after a period of strong multi year total returns. The stock recently closed at $199.19, and investors are weighing how its current valuation lines up with fundamentals. See our latest analysis for Tenet Healthcare. While the share price has eased in the very short term, with a 7 day share price return of a 4.35% decline to US$199.19, Tenet Healthcare’s 1 year total shareholder return of 56.07%...

If you are wondering whether Uranium Energy is priced attractively right now, the first step is to separate the eye catching share price moves from the company’s underlying value. The stock most recently closed at US$15.55, with returns of 6.9% over 7 days, 20.4% over 30 days, 18.6% year to date, 125.4% over 1 year and a very large gain over 5 years. Recent attention on uranium related names, including Uranium Energy, has focused on supply security, nuclear power policy discussions and how...

If you are wondering whether Palantir Technologies is priced for perfection or still offers value, starting with a clear look at the current share price and fundamentals can help frame the next move. The stock has seen a 0.4% decline over the last 7 days and a 2.5% decline over the last 30 days, yet it is still up 6.6% year to date and 171.5% over the last year, with a very large 3 year return and a more than 5x 5 year return. Recent discussion around Palantir has focused on its role in...

Conference guidance puts Q4 and 2025 in sharper focus Danaher (DHR) updated its fourth quarter 2025 outlook ahead of the J.P. Morgan Healthcare Conference, indicating that Q4 core revenue and non-GAAP earnings are tracking toward the upper end of its previous guidance range. Management also highlighted strong bioprocessing performance and better than expected Life Sciences and Diagnostics revenue for the quarter. This update sets the stage for CEO Rainer M. Blair’s detailed comments at the...

Redwire (RDW) is reshaping its business after fully integrating the Edge Autonomy acquisition, unifying uncrewed aerial systems and defense technology under one brand while restructuring around two core segments: Space and Defense Tech. See our latest analysis for Redwire. Redwire's share price has recently cooled, with a 1-day share price return showing a 4.88% decline after earlier gains. The 30-day share price return of 39.09% suggests momentum has recently been building, even as the...

If you are wondering whether SM Energy is a bargain or a value trap at its recent price around US$18.17, you are asking the right question. The stock has had a tough run, with a 7.1% decline over the last 30 days, a 5.0% drop year to date, and a 56.9% fall over the past year, even though the 5 year return sits at 124.6%. Recent moves in SM Energy have come against a backdrop of ongoing attention on US oil and gas producers, sector wide capital discipline, and investor focus on balance sheet...

Earlier this week, NVIDIA and Eli Lilly and Company unveiled a first-of-its-kind AI co-innovation lab in South San Francisco, committing up to US$1.00 billion over five years to fuse Lilly’s drug discovery expertise with NVIDIA’s BioNeMo platform, accelerated computing and AI infrastructure. The collaboration’s continuous learning system, linking automated wet labs with AI-powered dry labs and digital twins of manufacturing, could materially reshape how Lilly discovers, develops and produces...

If you are wondering whether Oracle's current share price really lines up with its business fundamentals, you are not alone. That is exactly what this article will unpack for you. Oracle's stock last closed at US$202.29, with returns of 4.4% over 7 days, 6.5% over 30 days, 3.4% year to date, 30.7% over 1 year, 136.7% over 3 years and 253.4% over 5 years. This naturally raises questions about what a fair price might look like now. Recent news around Oracle has focused on its broader position...

Why HCI Group (HCI) Is Back in Focus Ahead of Earnings HCI Group (HCI) is drawing attention after its share price slipped 1.87% in the latest session, as investors look ahead to an upcoming earnings report that is expected to show very large EPS growth versus last year. See our latest analysis for HCI Group. At a share price of US$176.06, HCI Group has had a mixed stretch recently, with a 1 month share price return of a 6.09% decline and a 3 month share price return of a 12.76% decline...

PC Connection (CNXN) has been in focus after reporting quarterly revenue of US$709.1 million, a 2.2% year-on-year decline that missed analyst revenue and EPS estimates, with the stock down about 4% since the release. See our latest analysis for PC Connection. At a share price of US$58.78, the recent 4% pullback after the results comes on top of a 1-year total shareholder return decline of 15.38%. However, the 3-year and 5-year total shareholder returns of 20.17% and 20.41% present a more...

BlackRock (BLK) has drawn fresh attention after announcing a global workforce reduction of about 1% shortly after reporting stronger than expected quarterly earnings and reporting increased institutional flows into its exchange traded funds. See our latest analysis for BlackRock. BlackRock shares trade at US$1,089.54, with a 90 day share price return of a 9.4% decline but a 1 year total shareholder return of 15.44%. This suggests longer term holders have seen stronger gains even as recent...

Prestige Consumer Healthcare (PBH) just moved to expand its TheraTears eye care line, announcing nationwide February 2026 launches for Eyelid Cleansing Wipes and Dry & Tired preservative free lubricant eye drops targeting screen related eye fatigue. See our latest analysis for Prestige Consumer Healthcare. The fresh TheraTears launches sit alongside a recent run of conference appearances and an upcoming fiscal 2026 third quarter earnings release. This is during a period where the share price...

President Donald Trump’s proposal for a US$200b mortgage bond purchase plan, paired with assurances that Opendoor Technologies (OPEN) is not targeted by a potential institutional buying ban, sparked fresh interest in the iBuyer’s rate sensitive stock. See our latest analysis for Opendoor Technologies. Those policy headlines have come after an already eventful stretch for Opendoor, with recent mortgage bond proposals, leadership changes and the Homebuyer.com acquisition all feeding into a rate...

IDEXX Laboratories (IDXX) has put a firm CEO succession plan in place, with Michael Erickson set to become President and Chief Executive Officer on May 12, 2026, as Jonathan Mazelsky moves to Executive Chair. See our latest analysis for IDEXX Laboratories. The CEO succession news comes after a strong run for long term holders, with the 1 year total shareholder return at 70.57% and the 5 year total shareholder return at 47.25%. The recent 90 day share price return of 11.72% suggests momentum...

Earlier in January 2026, Duolingo announced that long-time board member and Audit Chair Gillian Munson will become Chief Financial Officer on February 23, 2026, succeeding outgoing CFO Matt Skaruppa, who will shift to an advisory role to support a smooth transition. The company paired this leadership change with preliminary fourth-quarter 2025 figures showing strong year-over-year growth in daily active users and bookings, even as management emphasized ongoing product investment over...

If you are trying to figure out whether GE Vernova's current share price really makes sense, you are in the right place. The stock is up 71.0% over the last year, even though it has seen a 5.0% decline over the past week, a 2.9% decline over the past month and a 4.0% decline year to date from its last close of US$652.09. Recent news coverage has focused on GE Vernova's position in the capital goods space and how investors are responding to its role in the wider energy transition. This...

If you are wondering whether RenaissanceRe Holdings is still good value at around US$270.10 per share, this breakdown is designed to help you make sense of the current price. The stock’s moves have been relatively muted recently, with a 0.7% decline over the last week, a 0.8% decline over the past month and year to date, and an 8.2% return over one year and 76.5% over five years. Recent attention on RenaissanceRe has centered on how the company is positioned within the insurance and...

Ichor Holdings, Ltd. ( NASDAQ:ICHR ) shares have had a really impressive month, gaining 47% after a shaky period...

Key Insights Given the large stake in the stock by institutions, NewtekOne's stock price might be vulnerable to their...